{"id":3719,"date":"2020-09-11T12:24:00","date_gmt":"2020-09-11T12:24:00","guid":{"rendered":"https:\/\/ingenewpharma.com\/nouvelles\/"},"modified":"2021-02-16T01:04:49","modified_gmt":"2021-02-16T01:04:49","slug":"nouvelles","status":"publish","type":"page","link":"https:\/\/ingenewpharma.com\/nouvelles\/?lang=fr","title":{"rendered":"Nouvelles"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"3719\" class=\"elementor elementor-3719 elementor-1405\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-65bbcb8 elementor-section-height-min-height elementor-section-boxed elementor-section-height-default elementor-section-items-middle\" data-id=\"65bbcb8\" data-element_type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[{&quot;jet_parallax_layout_image&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;_id&quot;:&quot;e148aec&quot;,&quot;jet_parallax_layout_speed&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;size&quot;:&quot;50&quot;,&quot;sizes&quot;:[]},&quot;jet_parallax_layout_bg_x&quot;:&quot;50&quot;,&quot;jet_parallax_layout_bg_y&quot;:&quot;50&quot;,&quot;jet_parallax_layout_image_tablet&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_mobile&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_type&quot;:&quot;scroll&quot;,&quot;jet_parallax_layout_direction&quot;:null,&quot;jet_parallax_layout_fx_direction&quot;:null,&quot;jet_parallax_layout_z_index&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size&quot;:&quot;auto&quot;,&quot;jet_parallax_layout_bg_size_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_animation_prop&quot;:&quot;transform&quot;,&quot;jet_parallax_layout_on&quot;:[&quot;desktop&quot;,&quot;tablet&quot;]}],&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t\t<div class=\"elementor-background-overlay\"><\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-bac2f1b\" data-id=\"bac2f1b\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-d2f4081 elementor-align-left elementor-widget elementor-widget-raven-heading\" data-id=\"d2f4081\" data-element_type=\"widget\" data-widget_type=\"raven-heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"raven-widget-wrapper\"><h1 class=\"raven-heading raven-heading-h1\"><span class=\"raven-heading-title \">Nouvelles<\/span><\/h1><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-fd34668 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"fd34668\" data-element_type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[{&quot;jet_parallax_layout_image&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;_id&quot;:&quot;1f1bed4&quot;,&quot;jet_parallax_layout_speed&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;size&quot;:&quot;50&quot;,&quot;sizes&quot;:[]},&quot;jet_parallax_layout_bg_x&quot;:&quot;50&quot;,&quot;jet_parallax_layout_bg_y&quot;:&quot;50&quot;,&quot;jet_parallax_layout_image_tablet&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_mobile&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_type&quot;:&quot;scroll&quot;,&quot;jet_parallax_layout_direction&quot;:null,&quot;jet_parallax_layout_fx_direction&quot;:null,&quot;jet_parallax_layout_z_index&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size&quot;:&quot;auto&quot;,&quot;jet_parallax_layout_bg_size_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_animation_prop&quot;:&quot;transform&quot;,&quot;jet_parallax_layout_on&quot;:[&quot;desktop&quot;,&quot;tablet&quot;]}]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-no\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-4e263b5\" data-id=\"4e263b5\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-5a19073 elementor-widget elementor-widget-heading\" data-id=\"5a19073\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<p class=\"elementor-heading-title elementor-size-default\">FILTRES<\/p>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5911703 elementor-widget elementor-widget-raven-posts\" data-id=\"5911703\" data-element_type=\"widget\" data-settings=\"{&quot;classic_show_pagination&quot;:&quot;yes&quot;,&quot;classic_pagination_type&quot;:&quot;load_more&quot;,&quot;classic_show_sortable&quot;:&quot;yes&quot;,&quot;_skin&quot;:&quot;classic&quot;,&quot;classic_layout&quot;:&quot;grid&quot;,&quot;classic_columns&quot;:&quot;3&quot;,&quot;classic_columns_tablet&quot;:&quot;2&quot;,&quot;classic_columns_mobile&quot;:&quot;1&quot;,&quot;query_posts_per_page&quot;:6,&quot;classic_show_all_title&quot;:&quot;yes&quot;,&quot;query_offset&quot;:0}\" data-widget_type=\"raven-posts.classic\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"raven-sortable\">\n\t\t\t<div class=\"raven-sortable-items\">\n\t\t\t\t<a class=\"raven-sortable-item raven-sortable-active\" data-category=\"-1\" href=\"#\">All<\/a><a class=\"raven-sortable-item\" data-category=\"72\" href=\"#\">Press Releases<\/a><a class=\"raven-sortable-item\" data-category=\"54\" href=\"#\">Scientific Resources<\/a>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"raven-posts raven-grid raven-grid-3 raven-grid-mobile-1 raven-grid-tablet-2\" data-post-id=\"3719\" data-archive-query=\"\" data-lang=\"\">\n\t\t\t\t<div class=\"raven-grid-item raven-post-item post-5292 post type-post status-publish format-standard hentry category-press-releases\">\n\t\t\t<div class=\"raven-post\">\n\t\t\t\t\t\t\t\t<div class=\"raven-post-content\">\n\t\t\t\t\t\t\t<div class=\"raven-post-meta\"><a class=\"raven-post-meta-item raven-post-date\" href=\"https:\/\/ingenewpharma.com\/2021\/12\/\" rel=\"bookmark\">December 22, 2021<\/a>\n<span class=\"raven-post-meta-divider\">|<\/span>\n<span class=\"raven-post-meta-item raven-post-categories\"><a href=\"https:\/\/ingenewpharma.com\/category\/press-releases\/\" rel=\"tag\">Press Releases<\/a><\/span><\/div>\n\t\t<h3 class=\"raven-post-title\"><a class=\"raven-post-title-link\" href=\"https:\/\/ingenewpharma.com\/ingenew-pharma-announces-the-completion-of-the-hesperidin-virtual-clinical-trial-in-covid-19-subjects\/\">Ingenew Pharma Announces the Completion of the Hesperidin Virtual Clinical Trial in COVID-19 Subjects<\/a><\/h3><div class=\"raven-post-excerpt\">Proof-of-concept of a virtual Phase 2 double-blind placebo-controlled clinical trial Hesperidin 1g daily reduced COVID-19 symptoms compared to placebo Montreal, December 22, 2021. Ingenew Pharma announces it has completed a<\/div>\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"raven-grid-item raven-post-item post-5226 post type-post status-publish format-standard hentry category-press-releases\">\n\t\t\t<div class=\"raven-post\">\n\t\t\t\t\t\t\t\t<div class=\"raven-post-content\">\n\t\t\t\t\t\t\t<div class=\"raven-post-meta\"><a class=\"raven-post-meta-item raven-post-date\" href=\"https:\/\/ingenewpharma.com\/2021\/02\/\" rel=\"bookmark\">February 16, 2021<\/a>\n<span class=\"raven-post-meta-divider\">|<\/span>\n<span class=\"raven-post-meta-item raven-post-categories\"><a href=\"https:\/\/ingenewpharma.com\/category\/press-releases\/\" rel=\"tag\">Press Releases<\/a><\/span><\/div>\n\t\t<h3 class=\"raven-post-title\"><a class=\"raven-post-title-link\" href=\"https:\/\/ingenewpharma.com\/new-clinical-trial-on-hesperidin\/\">New Clinical Trial on Hesperidin<\/a><\/h3><div class=\"raven-post-excerpt\">A natural product to fight symptoms related to COVID-19 The Montreal Heart Institute (MHI) is launching a new clinical trial to evaluate the effect of hesperidin on symptoms related to<\/div>\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"raven-grid-item raven-post-item post-3460 post type-post status-publish format-standard hentry category-scientific-resources\">\n\t\t\t<div class=\"raven-post\">\n\t\t\t\t\t\t\t\t<div class=\"raven-post-content\">\n\t\t\t\t\t\t\t<div class=\"raven-post-meta\"><a class=\"raven-post-meta-item raven-post-date\" href=\"https:\/\/ingenewpharma.com\/2020\/09\/\" rel=\"bookmark\">September 3, 2020<\/a>\n<span class=\"raven-post-meta-divider\">|<\/span>\n<span class=\"raven-post-meta-item raven-post-categories\"><a href=\"https:\/\/ingenewpharma.com\/category\/scientific-resources\/\" rel=\"tag\">Scientific Resources<\/a><\/span><\/div>\n\t\t<h3 class=\"raven-post-title\"><a class=\"raven-post-title-link\" href=\"https:\/\/ingenewpharma.com\/valeo-pharma-receives-hesperco-natural-product-license-approval\/\">Valeo Pharma Receives Hesperco(TM) Natural Product License Approval From Health Canada<\/a><\/h3><div class=\"raven-post-excerpt\">HespercoTM capsules for immune system support to be commercially available by end of September 2020 HespercoTM pre-sales now available at online store \u00a0 MONTREAL, QUEBEC , September 3, 2020 \u2013<\/div>\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"raven-grid-item raven-post-item post-2825 post type-post status-publish format-standard has-post-thumbnail hentry category-press-releases\">\n\t\t\t<div class=\"raven-post\">\n\t\t\t\t\t\t\t\t<div class=\"raven-post-content\">\n\t\t\t\t\t\t\t<div class=\"raven-post-meta\"><a class=\"raven-post-meta-item raven-post-date\" href=\"https:\/\/ingenewpharma.com\/2020\/07\/\" rel=\"bookmark\">July 13, 2020<\/a>\n<span class=\"raven-post-meta-divider\">|<\/span>\n<span class=\"raven-post-meta-item raven-post-categories\"><a href=\"https:\/\/ingenewpharma.com\/category\/press-releases\/\" rel=\"tag\">Press Releases<\/a><\/span><\/div>\n\t\t<h3 class=\"raven-post-title\"><a class=\"raven-post-title-link\" href=\"https:\/\/ingenewpharma.com\/ortho-regenerative-technologies-enters-into-licensing-agreement-to-expand-the-scope-of-its-technological-platform-applications\/\">Ortho Regenerative Technologies Enters Into Licensing Agreement To Expand The Scope Of Its Technological Platform Applications<\/a><\/h3><div class=\"raven-post-excerpt\">Montreal, QC, May 20, 2020 \u2013 Ortho Regenerative Technologies Inc. (CSE: ORTH) (\u201cOrtho RTI\u201d or the \u201cCompany\u201d), an emerging orthobiologics company, today announced that it has entered into a strategic<\/div>\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Nouvelles FILTRES AllCOVIDNon classifi\u00e9(e) September 11, 2020 Ortho Regenerative Technologies conclut un accord de licence pour \u00e9largir la port\u00e9e de ses applications de plateforme technologique Montr\u00e9al, QC, le 20 mai 2020 \u2013 Ortho Regenerative Technologies Inc. (CSE: ORTH) (\u00ab&nbsp;Ortho RTI&nbsp;\u00bb ou la \u00ab&nbsp;Soci\u00e9t\u00e9&nbsp;\u00bb), une soci\u00e9t\u00e9 d\u2019orthobiologique \u00e9mergente, a annonc\u00e9 aujourd\u2019hui qu\u2019elle a conclu un accord [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"full-width.php","meta":{"footnotes":""},"acf":[],"_links":{"self":[{"href":"https:\/\/ingenewpharma.com\/wp-json\/wp\/v2\/pages\/3719"}],"collection":[{"href":"https:\/\/ingenewpharma.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ingenewpharma.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ingenewpharma.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ingenewpharma.com\/wp-json\/wp\/v2\/comments?post=3719"}],"version-history":[{"count":0,"href":"https:\/\/ingenewpharma.com\/wp-json\/wp\/v2\/pages\/3719\/revisions"}],"wp:attachment":[{"href":"https:\/\/ingenewpharma.com\/wp-json\/wp\/v2\/media?parent=3719"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}